A BLOCKCHAIN
PLATFORM
ENABLING AUTONOMOUS, DEFERRED PURCHASES OF EMERGING BIOMED AS WELL AS ADDITIONAL SERVICES, NOT YET AVAILABLE
Share your dream
Token Presale is Live!
Get a 50% discount right now
+5% when buying > 10 ETH
$678.169 — $1.000.000 
We accept:
Globally top rated Token Sale at ICO Bench
40
Days
5
Hours
47
Minutes
27
Seconds

Start: 22 March - 30 May 2018

Initial price 1 ETT:

0.01 usd

Tokens for sale:

200,000,000 eet

Target Presale Cap:

2’000’000 usd

Current price

$0,010 $0,014 $0,018 $0,021
200.000.000 250.000.000 500.000.000 1.000.000.000

Start: June 1 - August 1, 2018

Price:

0,014 - 0,018 - 0,021usd

Tokens for sale:

1,750,000,000eet

Soft cap:

7,000,000 usd

Hard cap:

To be defined after the Presale

Current price

$0,010 $0,014 $0,018 $0,021
200.000.000 250.000.000 500.000.000 1.000.000.000

The purpose
of the ETT

Current
price

Total
amount

Accepted currencies

Token burning

The Synergy of high quality services
integrated on the blockchain

We combined the existing services of four different industries to create a new product — a system that guarantees autonomous, deferred purchases of emerging biomedical and other vital services that are currently unavailable

data-active="false">

SMART CONTRACT

Writing data into the blockchain will initiate the process of constant monitoring of opportunity to purchase vital services for the client, and later will launch autonomous purchasing in the form of a smart contract

PURPOSE TRUST

Autonomous analysis of contractors and acquisition of required services once they become ethical, legal, and available on the market

BIOTECH

Preserving clients' biomaterial by all available means using the best existing technologies

CUSTOMER

Personal selection of packaged products and services required to achieve the final objective

FULFILLING THE DREAM

Autonomous analysis of contractors and acquisition of required services once they become ethical, legal, and available on the market

ASSET MANAGEMENT

Effective asset management of trust funds will lead to a high quality of client's life, rehabilitation, and adaptation to new conditions

An example of returns with the minimum amount of contribution of $400 000 at 7% per annum calculated by the compound interest formula:

50 years – $11,782,810

100 years – $347,086,530

150 years – $10,224,136,619

200 years – $301,172,648,661

A platform where anyone can choose attractive dreams for automatic future fulfillment

1.

ETT Tokens – this is the "fuel" to automate the fulfillment of our clients' goals

2.

Tokens ETT – This is the platform currency, which is, including, "kickstarter" projects and services in the field of biotechnology

3.

Projects implemented with the help of Eternal Trusts platform in the field of biotechnology will also be sold in ETT tokens

4.

Eternal Trusts will pay for the services required by its clients for ETT tokens, creating liquidity in emerging markets only

Client Personal Account Prototype

{{ desc }}

Dream, task, objective

Contract term

Filling up
the trust fund

Biomaterial storage

Start

Execution of the smart contract

{{ date[0].val }}
year
{{ date[1].val }}
month
{{ date[2].val }}
days
{{ date[3].val }}
hours
{{ date[4].val }}
minutes
{{ date[5].val }}
seconds

The objective

{{ returnData.name }}

Feasibility check

Objective feasible

Potential providers
  • {{ item }}

Reliability check

Objective feasible

Additional objectives feasibility
  • Adjustment of legal status
  • Social adaptation
  • Sufficiency of funds

Objective feasible

{{ returnData.field1 }}

Objective feasible

Adjustment of legal status

Objective feasible

Social adaptation

Objective feasible

Health recovery

Objective feasible

{{ returnData.field2 }}

Objective feasible

{{ returnData.field3 }}

Objective feasible

Objective feasible

10 crucial inventions and discoveries

2003

The Human Genome Project was completed. The result: complete data about the location and sequence of human genes on all 46 chromosomes. The National Human Genome Research Institute http://www.genome.gov

2007

Scientists used skin cells to create embryonic stem cells http://www.genome.gov

2010

Dr. Craig Venter announced the creation of the first synthetic "life" by transplanting a chemically synthesized genome into a bacterial cell. J. Craig Venter Institute http://www.jcvi.org https://www.ncbi.nlm.nih.gov

2012

Dr. Craig Venter announced the creation of the first synthetic "life" by transplanting a chemically synthesized genome into a bacterial cell. J. Craig Venter Institute https://www.ncbi.nlm.nih.gov

2013

A former US president Barack Obama announced the BRAIN Initiative project aimed at modelling the brain on a supercomputer. National Institutes of Health (NIH) https://www.braininitiative.nih.gov/

2014

A former US president Barack Obama announced the BRAIN Initiative project aimed at modelling the brain on a supercomputer. National Institutes of Health (NIH) http://www.ncbi.nlm.nih.gov

2015

Researchers from China used CRISPR to modify the genome of a human embryo. Guangzhou University of Chinese Medicine (GZUCM) https://link.springer.com

2016

Bioengineers created a heart-on-a-chip using a 3D printer. Harvard University https://www.nature.com

2016

First aldehyde-stabilized cryopreservation of rabbit brain without any synaptic damage. 21 Century Medicine http://www.21cmpublications.com

2017

Human blood stem cells were first grown in a laboratory. The National Center for Biotechnology Information https://www.ncbi.nlm.nih.gov

ROADMAP

2015

DEVELOPMENT OF A SAMPLE TRUST AGREEMENT, LEGAL SOLUTION

2017

EXTRA LONG-TERM ASSET MANAGEMENT STRATEGY

2018 FEBRUARY

PERSONAL ACCOUNTS, WALLETS

2018 APRIL

REGISTRATION OF ALL REQUIRED LEGAL ENTITIES, ETHEREUM-BASED MVP

2018 MAY

BETA-VERSIONS OF THE SMART CONTRACT, IT-INFRASTRUCTURE, ALGORITHMIZATION AND API

2018 JUNE

ESTABLISHMENT OF INVESTMENT AND BIOTECH SUPERVISORY BOARDS

2018 AUGUST

REGISTRATION OF ASSET MANAGEMENT FUND

2018 SEPTEMBER

CONCLUSION OF INFRASTRUCTURE AGREEMENTS. OPENING OF REPRESENTATIVE OFFICE IN ZURICH

2018 OCTOBER

ACTIVE PROMOTION OF OUR PRODUCT THROUGH PARTNER NETWORKS

2018 DECEMBER

THE FIRST PARTNER TOKEN SALE ON OUR PLATFORM

2019 FEBRUARY

FULLY FUNCTIONAL PLATFORM

Market Potential

Number of potential clients with net worth more than $30 000 000

Number of potential clients with net worth more than $5 000 000 to $30 000 000

Number of potential clients with net worth more from $1 000 000 to $5 000 000

Target audience

Distribution of funds

chart1

Distribution of the ETT Tokens

chart1

Team

KIRILL SILVESTROV, MBA

CEO

MARK LEA

Head of Legal, creature and administration of trusts

BENOIT VULIC, CFA

Chief Investment Officer, asset Management

ARTEM ANANYAN

Chief Financial Officer

ALEXANDER GORSHENEV

Chief Technical Officer IT, architecture of the blockchain

ILYA SAPRANIDI

Chief Business Developer, Interaction with medical contractors

ALMIR SALIMOV

Investor Relations, Interaction with investors

VADIM PEREDOLSKY

Art Director, marketing

ELENA ABRAMOVA

Artist, designer

Vladimir Nikitin

Crypto Community Expert

Renown cryptocurrency expert and ICO advisor (Top-5 worldwide ICObench Certified Expert). As an active supporter and advocate of blockchain technology, I provide consultancy and advice to selected ICOs in the CIS region. My network in the crypto community counts over 30 000 members.

Advisers

Randal A. Koene

Biomedicine

Randal A. Koene, Dutch neuroscientist and neuroengineer, co-founder of carboncopies.org, the outreach and roadmapping organization for advancing Substrate-Independent Minds. Аormer Professor at the Center for Memory and Brain of Boston University, co-founder of the Neural Engineering Corporation of Massachusetts.

Sergey Kiselev

Strategy

Former partner of the consulting group Mckinsey in the CIS with more than ten years of experience in determining company development strategies and working with the regulation of various industries. He is engaged in the development of business in Europe in the innovative transport sector, including cloud and blockchain technologies.

Igor Karavaev

Investor Relations

Serial Advisor for Investor Relations projects, top-expert ICOBench. Executive Director Skolkovo Foundation, a leading high-tech incubator startups. Head of Strategy, Business Development, investments of the largest multinational companies

Jillian Godsil

PR

Jillian has held senior positions with global PR companies in Sydney, Singapore, London and Dublin. She was PRO of Iona Technologies (Ireland’s first company to float on NASDAQ). She is a freelance journalist with CryptoCoin.News, The Irish Independent and The Irish Times. She has her own radio show on DublinCityFM. She is advisor to a number of ICOs, has been named a Crypto Queen by In Zero Conferences as well as listed in the 50 most influential women in blockchain rollcall.

Aleksei Pupyshev

Intelligent Systems Development & Architecture

Experienced Data Scientist and Artificial Intelligence Applications Consultant. Neuroscientist. Former Data Science & Engineering Group Manager at Wrike. Former Artificial Intelligence Expert at MailRu Group. Founder, Research & Strategy at Ventuary, an analytical platform of tokensale campaigns. Organizer of the Blockchain Analytics MeetUp.

F.A.Q

The blockchain is a critically important component of our product that allows for the necessary level of security through decentralizing data storage. The agreements with our clients are not only stored in the blockchain, but also autonomously executed in the format of smart contracts with human factor minimized.

ETT is a necessary element for our ecosystem: creating individual smart contracts and storing legal agreements is paid for only by ETT tokens.

We have finalized the legal and the financial parts of our multi-сomponent product, including the trust agreement and a unique investment strategy. We also have prior agreements with the most suitable medical contractors. Therefore, we do have a product ready to be scaled. However, the blockchain and smart contract technologies make our product better, more stable and durable. This is what we begin to work on in parallel with the Token Sale.

The team of Eternal Trusts consists of highly-skilled expers with many years of experience in the field of asset management, trust establishment and administration, blockchain development, biomedicine, bank investment services. Our executives consult goverments of various countries on issues relating to trust law, manage assets of the most wealthy entrepreneurs, assign grants among the most highly developed medical companies.

The Token Sale starts at June 1 and ends at 1 August (or earlier, if the hard cap is reached). If you would like to buy more tokens worth more than 50 ETH, please contact our representatives on the Telegram channel.

Pre-sale starts at March 22, 2018 and ends at May 30, 2018. In this period, we provide a unique opportunity to purchase tokens at the 50% discount to the Token Sale price.

We accept Bitcoin (BTC), Ethereum (ETH), BitcoinCash, DASH, Litecoin.

The uniqueness of the token is that it allows you to buy a unique product which is impossible to buy through any different means.